High Peak Royalties Limited (ASX:HPR – Get Free Report) insider David Croll acquired 699,822 shares of the firm’s stock in a transaction that occurred on Monday, April 15th. The stock was purchased at an average price of A$0.06 ($0.04) per share, with a total value of A$41,989.32 ($27,089.88).
David Croll also recently made the following trade(s):
- On Wednesday, April 3rd, David Croll acquired 280,000 shares of High Peak Royalties stock. The stock was purchased at an average price of A$0.06 ($0.04) per share, with a total value of A$16,520.00 ($10,658.06).
- On Monday, March 25th, David Croll bought 138,447 shares of High Peak Royalties stock. The shares were bought at an average price of A$0.06 ($0.04) per share, with a total value of A$7,891.48 ($5,091.28).
- On Wednesday, February 14th, David Croll bought 50,000 shares of High Peak Royalties stock. The shares were bought at an average price of A$0.06 ($0.04) per share, with a total value of A$2,750.00 ($1,774.19).
- On Friday, February 2nd, David Croll bought 230,000 shares of High Peak Royalties stock. The shares were bought at an average price of A$0.05 ($0.03) per share, with a total value of A$12,420.00 ($8,012.90).
High Peak Royalties Stock Performance
The company has a debt-to-equity ratio of 11.82, a quick ratio of 2.55 and a current ratio of 1.15.
High Peak Royalties Company Profile
High Peak Royalties Limited, together with its subsidiaries, engages in the acquisition of royalty and exploration interests in oil and gas assets in the United States. It also holds 100% interest in four geothermal energy licenses covering 2,767 square kilometers located in South Australia. The company was incorporated in 2006 and is based in Sydney, Australia.
Further Reading
- Five stocks we like better than High Peak Royalties
- What is MarketRankā¢? How to Use it
- J.B. Hunt Hits the Skids: Lower Prices to Come
- What Are Trending Stocks? Trending Stocks Explained
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
- Stock Dividend Cuts Happen Are You Ready?
- Abbott Laboratories Outlook is Healthy: Buy the Dip
Receive News & Ratings for High Peak Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for High Peak Royalties and related companies with MarketBeat.com's FREE daily email newsletter.